Printer Friendly

BIO-VASCULAR ANNOUNCES NEW DIRECTOR OF REGULATORY AFFAIRS

       BIO-VASCULAR ANNOUNCES NEW DIRECTOR OF REGULATORY AFFAIRS
    ST. PAUL, Minn., Nov. 18 /PRNewsire/ -- Bio-Vascular, Inc. (NASDAQ: BVAS) a St. Paul-based company, announced that Bruce A. MacFarlane, Ph.D. has joined the company as their new director of regulatory affairs.
    MacFarlane received his B.A. in combined sciences, magna cum laude, from Yale University and his Ph.D. in physiological psychology from the University of Pennsylvania.  In addition, MacFarlane was postdoctoral fellow at the Johns Hopkins University.  Most recently, MacFarlane was the director of regulatory affairs for Medical Devices, Inc., a St. Paul-based company.
    MacFarlane will be responsible for the development of the company's various regulatory applications as they relate to the company's existing and future products.  He will be instrumental in the successful guidance of those applications through the regulatory process.
    Bio-Vascular, Inc. is a manufacturer and distributor of proprietary consumable medical products used in cardiac and vascular surgery.  Bio- Vascular's common stock is traded on the national over-the-counter market under the symbol BVAS.
    -0-                           11/18/91
    /CONTACT:  John H. Darnall, Jr. of Bio-Vascular, 612-631-3529/
    (BVAS) CO:  Bio-Vascular, Inc. ST:  Minnesota IN:  MTC SU:  PER KH -- MN005 -- 1361 11/18/91 11:04 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 18, 1991
Words:195
Previous Article:THREE SITES AT USX CLAIRTON WORKS CERTIFIED AS WILDLIFE HABITATS
Next Article:CENTOCOR AND CORVAS SIGN ANTIBODY AGREEMENT
Topics:


Related Articles
BIO-VASCULAR ANNOUNCES NEW VICE PRESIDENT OF OPERATIONS
BIO-VASCULAR NAMES SCHANKERELI DIRECTOR OF RESEARCH AND DEVELOPMENT
DARNALL RESIGNS AS BIO-VASCULAR CHIEF EXECUTIVE; THREE EXECUTIVES TO FORM NEW OFFICE OF PRESIDENT
BIO-VASCULAR PICKS LYONS AS CHIEF EXECUTIVE OFFICER
BIO-VASCULAR NAMES KEMAL SHANKERELI VICE PRESIDENT OF RESEARCH AND DEVELOPMENT
BIO-IMAGING TECHNOLOGIES NAMES TERRENCE P. BRENNAN PRESIDENT AND CEO; FORMER PRESIDENT RESEARCH DATA CORP.
KARCANES ELECTED CEO OF BIO-VASCULAR, INC.
BIO-VASCULAR PROMOTES BRUCE A. MACFARLANE, PH.D., TO VICE PRESIDENT, REGULATORY AFFAIRS AND QUALITY ASSURANCE
AVE Promotes Scott Solano to President and Chief Executive Officer

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters